New targeted therapy for advanced prostate cancer shows anti-tumor activity in clinical trials
Few available treatment options exist once prostate cancer has spread to other parts of the body and has failed to respond to therapies that involve blocking the male hormone androgen. Patients with advanced, hormone-refractory ...
Cancer
Nov 07, 2012 |
not rated yet |
0
Liver metastases and its prognostic significance in men with metastatic prostate cancer
Liver metastases predicts shorter overall survival in men with metastatic castration-refractory prostate cancer (mCRPC), according to data being presented at the 2012 American Society of Clinical Oncology Annual Meeting in ...
Cancer
May 31, 2012 |
not rated yet |
0
Baseline hormone levels may predict survival in metastatic, castration-resistant prostate cancer
Patients with castration-resistant prostate cancer treated with the androgen inhibitor abiraterone and who had high baseline hormone levels had longer overall survival compared with patients with low hormone levels, according ...
Cancer
Apr 03, 2012 |
not rated yet |
0
Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival
Jefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind ...
Cancer
Jan 12, 2012 |
not rated yet |
0
More radionuclide therapy is better for prostate cancer patients
For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November ...
Cancer
Nov 01, 2011 |
not rated yet |
0
Targeted cancer therapy kills prostate tumor cells
A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's ...
Cancer
Jun 06, 2011 |
not rated yet |
0
|
